BIOPHARMA BOSTON
THE FUTURE OF ALLIANCES STARTS HERE
November 9-11, 2026
Register Now
Early Bird Discount Ends September 25
November 9-11, 2026
Register Now
Early Bird Discount Ends September 25
Menu
The Future of Biopharma Alliances in an AI-Driven, High-Complexity World
What to Expect
Three days built by practitioners, for practitioners. Every session is chosen for its real-world relevance, which means you'll leave with strategies, frameworks, and connections you can actually use.
Sessions That Reflect the Work You Do
The 2026 program covers what's actually changing the job: AI moving from experiment to daily toolkit, governance models stretching to handle three, four, or more partners at once, and alliance leaders being asked to own value realization, not just process. No product pitches. No purely theoretical topics. Just the real work our community comes for.
What You'll Walk Away With
- Actionable strategies from 50+ alliance leaders and practitioners
- High-value connections with peers from pharma, biotech, and beyond
- 12 professional development hours toward CA-AM or CSAP certification renewal
“Networking with peers who truly understand the art and science of alliances was game-changing. I connected with leaders across industries whose insights have reshaped how our teams think about collaboration and value creation.” ~ Kristin Rosner, PhD, CSAP, CA-AM, Senior Director, Global R&D Alliance Management, Takeda
Featured Speakers
Katherine Kendrick, CSAP, CA-AM, Executive Director, Head of Alliance Management, Jazz Pharmaceuticals
Arne Wörn, PhD, Global Head of Alliance Management, Novartis
Vivian Berlin, PhD, Executive Director, Harvard Medical School, Harvard University
Chris Coburn, Chief Innovation Officer, Mass General Brigham
Aram Donigian, Clinical Professor of Business Administration, Faculty Director, Tuck Business Bridge Program, Dartmouth
Aleksey Gerasyuto, PhD, Senior Vice President, Discovery & Preclinical Development Sciences, Schrödinger
Program
Sessions and times are subject to change
| 1:00-5:00 | Board of Directors Meeting (Invite only) |
| 6:00-8:00 | Board of Directors Dinner (Invite only) |
| 8:00-2:30 |
Alliance Essential Course (separate registration and fee required) |
| 8:00-2:30 | Applied Alliance Management Course formerly called the CA-AM Exam Prep (separate registration and fee required) Swati Prasad, PhD, CSAP CA-AM, Alloy Therapeutics |
| 8:00-2:30 | Alliance Strategy & Leadership Course (separate registration and fee required) Ann Trampas, CSAP, CA-AM, University of Illinois at Chicago |
| 8:00-2:30 | Mastering Alliance Management: Driving Clarity, Value, and Influence in Alliance Leadership Course (separate registration and fee required) Vickie Dalton, PsyD & Nick Palmer |
| 8:30-12:30 | ASAP Advisory Council Meeting (w/ the Board of Directors) & Luncheon (Invite only) |
| 12:00-2:00 |
Boston Dine-Arounds Kick off your BioPharma Boston experience with a casual lunch alongside a small group of fellow attendees. These intimate dine-arounds are a great way to connect and network before the conference begins. An additional fee applies. Sign up under Networking Add-Ons in the conference registration. |
| 11:30-2:30 |
Executive Leadership Luncheon & Forum (Invite only) |
|
DAY 1: ALLIANCE LEADERSHIP IN A CHANGING WORLD |
|
| 3:00-3:15 |
BioPharma Boston Kick-Off, Nicole Boston, CAE, CA-AM, ASAP; Katherine Kendrick, CSAP, CA-AM, Jazz Pharmaceuticals; Arne Worn, Novartis |
| 3:15-3:45 |
Aram Donigian, Tuck Business Bridge Program at Dartmouth |
|
3:45-4:15 |
New Global Innovation Ecosystems: China TBD |
|
4:30-5:15 |
Leading Alliances in the Age of AI, Brooke Paige, CSAP, CA-AM, Novartis (invited), Crystal Dillon, Eli Lilly, CA-AM (invited), & Fern McSorley, PhD, Isomorphic Labs (invited) |
|
5:15-5:45 |
The External Forces No Alliance Can Ignore: How Policy, Pricing, & Geopolitics Are Reshaping Partnerships, Mark Bolton, Jazz Pharmaceuticals |
|
5:45-6:00 |
Alliance Excellence Awards, Katherine Kendrick, CSAP, CA-AM, Jazz Pharmaceuticals & Nicole Boston, CAE, CA-AM, ASAP |
| 6:00-8:00 | Welcome and Awardee Celebration Reception (all invited) |
| 6:00 - 7:00 |
Morning Run - Free Activity
Lace up and explore Boston's rich history on foot with fellow attendees-whether you run, jog or walk, it's a perfect way to connect and energize. |
| 6:45-7:45 |
CSAP Breakfast (invite only)
|
|
DAY 2: AI, DIGITAL TRANSFORMATION, AND NEW INNOVATION MODELS
|
|
| 8:00-8:10 |
Welcome Back, Katherine Kendrick & Arne Worn
|
| 8:10-8:40 |
From Discovery to Delivery: Building the Partnerships That Advance Innovation, Chris Coburn, Mass General Brigham
|
| 8:40-9:10 |
Aleksey Gerasyuto, PhD, Schrödinger
|
| 9:10-9:40 |
TBD
|
| 9:40- 10:10 |
Break
|
| 10:10-10:55 |
Building Successful AI-Enabled Discovery Alliances, Moderated by Kristin Rosner, PhD, CSAP, CA-AM, Takeda; Frances Anastassacos, PhD, Nabla Bio, Karen Berna, CSAP, CA-AM, Jazz Pharmaceuticals Echoe Bouta, PhD, Takeda, Kris Deibler, PhD, Novo Nordisk Artificial intelligence (AI) and machine learning (ML) are reshaping drug discovery, accelerating innovation while introducing new partnership complexities. From business development negotiations through alliance execution, organizations must navigate evolving challenges around intellectual property, data governance, proprietary algorithms, and cross-functional collaboration. Success depends on balancing innovation with appropriate protections while aligning scientific, technology, and alliance management teams around shared objectives. In this interactive panel discussion, experienced pharmaceutical and biotechnology leaders will share practical strategies for structuring, launching, and managing AI-enabled discovery collaborations. Attendees will gain real-world insights into negotiating agreements, fostering trust and transparency, protecting valuable assets, and establishing governance practices that enable agile, productive partnerships capable of delivering long-term scientific and business value.
|
|
10:55-11:40 |
TBD |
|
11:50-12:30 |
BREAKOUTS |
|
Track 1 AI, Digital Innovation & the Future of Alliance Management |
Before the Bots: Building The Foundation for AI-Enabled Alliance Success, Jennifer Christian, AbbVie & Melanie Patterson, PhD, AbbVie |
|
Track 2 Alliance Leadership & Value Creation |
From One Way to Many: Moving From a Single Partnership Portfolio, Krista Durney, PhD, Valo Health & Nancy Griffin, EdD, CSAP, CA-AM, Valo Health |
|
Track 3 Complex Partnerships, Governance & Cross Sector Collaborations |
Novel Governance Models for AI-Enabled Alliances: Scaling Beyond Bilateral Structures to Multi-Partner Complex Ecosystems, Swati Prasad, PhD, CSAP, CA-AM, Alloy Therapeutics |
|
Track 4 Global Collaboration, Discovery Partnerships & Academia |
Navigating Academia: Overcoming Challenges & Building High-Impact Academic Alliances, Kimberly Griffin, PhD, Stanford University, Sabrina Kamran, PhD, CA-AM, Boston Children's Hospital, Matthew Moscato, Nationwide Children's Hospital, & Seohee You, PhD, University of Michigan |
|
12:30-1:30 |
Lunch |
|
12:30-1:30 |
Academic Alliances Peer Group Lunch |
|
1:30-1:35 |
Welcome Back |
|
1:35-2:05 |
Vivian Berlin, PhD, Harvard University |
|
2:05-2:35 |
TBD |
|
2:35-3:05 |
Afternoon Puppy Break (yes, puppies!) |
|
3:05-3:45 |
Breakouts |
|
Track 1 AI, Digital Innovation & the Future of Alliance Management |
What Changes When AI Enters the Alliance Managers Toolkit?, Stefan Walke, PhD, CA-AM, Boehringer Ingelheim |
|
Track 2 Alliance Leadership & Value Creation |
Alliance Leaders' Evolving Mandate: Owning Value Realization, Jan Twombly, CSAP, CA-AM, The Rhythm of Business
|
|
Track 3 Complex Partnerships, Governance & Cross Sector Collaborations |
Triangular Alliances in Biopharma: Integrating External Innovation Without Breaking the Core Partnership, Gregg Jewett, Genmab & Fernando Maellas, Argnex |
|
Track 4 Global Collaboration, Discovery Partnerships & Academia |
Strategic use of Alliance Management Best Practice Across Sectors Steve Andrews, PhD, University of Cambridge, Fiona Ducotterd, PhD, CSAP, CA-AM ARUK Drug Discovery Institute, University College London, Fiona Jeganathan, PhD, ARUK Drug Discovery Institute, University College London & Emma Mead, PhD, Oxford University |
|
3:55-4:35 |
BREAKOUTS |
|
Track 1 AI, Digital Innovation & the Future of Alliance Management |
Introducing MAESTRO: Building a Practical Digital Backbone for Modern Alliance Management, Karen Berna, CSAP, CA-AM, Jazz Pharmaceuticals |
|
Track 2 Alliance Leadership & Value Creation |
Who Leads When No One is in Charge? The Alliance Manager's Role in Shaping Leadership in 50:50 Collaborations, Andi Gardner, PharmD, CA-AM, Biogen & Jennifer Berg, Supernus Pharmaceuticals |
|
Track 3 Complex Partnerships, Governance & Cross Sector Collaborations |
From Silos to Synery: Making Complex Governance Work for siRNA Innovation, Amy Arthur, PhD, ADARx & Allison Hoch, PhD, Abbvie |
|
Track 4 Global Collaboration, Discovery Partnerships & Academia |
Designing an Ecosystem for Impact: The LifeArc-CF Trust Translational Innovation Hub, Thunicia Moodely, PhD, CA-AM, LifeArc & Rebecca Wilson, PhD, CA-AM, LifeArc |
|
4:45-5:25 |
BREAKOUTS |
|
Track 1 AI, Digital Innovation & the Future of Alliance Management |
GA Catalyst AI: How Agentic AI is Reshaping the Alliance Leader's Role as a Strategic Navigator, Ori Maller, PhD, Bristol Myers Squibb |
|
Track 2 Alliance Leadership & Value Creation |
Sustainable Alliance Management: Why People First Leadership, Communication, and Trust Drive Partnership Success, Niccolo Ciuffi, CA-AM, mAbxience |
|
Track 3 Complex Partnerships, Governance & Cross Sector Collaborations |
The Alliance Behind the Alliance: Aligning Internally to Deliver Externally, Jessica Goodman, PhD, CSAP, CA-AM, Takeda, Andrew Ferguson, PhD, CA-AM, Takeda, Neha Garg, PhD, Derek Smith, Takeda, & Aaron Welch, Takeda |
|
Track 4 Global Collaboration, Discovery Partnerships & Academia |
One Partner, Multiple Interfaces: Delivering One Alliance Experience, Lauren Bautista, Bristol Myers Squibb & Melissa Nifenecker, Bristol Myers Squibb |
|
5:25-5:55 |
Grab a Refreshment and Head to Dinner |
|
8:30-10:00 |
After Glow Reception (all invited) Sponsored by Vantage Partners |
| 6:30 - 7:30 | Morning Yoga - Free Activity Rise and Renew with a calming morning yoga session led by Swati Prasad. Mats are provided-just bring your breath and start your day with intention. Space is limited to 20 participants. Sign up under Networking Add-Ons in the conference registration |
| 7:30-8:30 | Breakfast |
|
8:30-8:40 |
WELCOME BACK DAY 3: THE FUTURE OF PARTNERSHIPS |
|
8:40-9:40 |
Alliance Discussion Groups - Topics coming soon |
|
9:40-10:10 |
TBD |
|
10:10-10:40 |
Break |
|
10:40-11:20 |
BREAKOUTS |
|
Track 1 AI, Digital Innovation & the Future of Alliance Management |
AI + EQ: The Future of Alliance Management Requires Both, Rita Galhano, PhD, CA-AM, EMD Serono |
|
Track 2 Alliance Leadership & Value Creation |
When Boundaries Blur: Navigating Role Clarity and Shared Accountability in Strategic Alliances, Anna Skabeev, MD, CA-AM, Teva Pharmaceuticals |
|
Track 3 Complex Partnerships, Governance & Cross Sector Collaborations |
Building a Scalable Clinical Supply Agreement Process Amid Rapid Growth: Establishing an Industry Standard, Lillian Phan, CA-AM, BeOne Medicines & Jake White, CA-AM, BeOne Medicines |
|
Track 4 Global Collaboration, Discovery Partnerships & Academia |
Partnering in China and Beyond: Navigating Cross-Border Alliances in a Global Innovation Ecosystem, Jacqueline Dim, PMP, CA-AM, Kailera Therapeutics, Sherket Peterson, PhD, AbbVie, Ashley Snyder, PharmD, Everest Medicines, & Yan Ye, Haisco |
|
11:30-12:10 |
BREAKOUTS |
|
Track 1 The Future of AI & Alliance Intelligence |
Session Information Coming Soon |
|
Track 2 The Human Future of Alliances |
The Wild Card: When One Person Knocks a Partnership Off Track, Katherine Ellison, CA-AM, Illumina, Maegan Harden, PhD, CA-AM, Illumina & Holly Lakin, CA-AM, Illumina |
|
Track 3 The Future of Technology, Risk & Value |
From Risk to Return: Maximizing IT Value for AM, Elnaz Atabakhsh PhD, AstraZeneca & Ajit Acharya, PhD, AstraZeneca |
|
Track 4 The Future of Alliance Leadership |
The Future of Alliance Leadership: Driving Strategic Value Across an Increasingly Complex Partnership Ecosystem, Aura Fratian, Xencor, Samuel Gosselin, CA-AM, SangeneBio, & Pamela Rodrigues, PhD, Bristol Myers Squibb |
| 12:20-12:50 | Prediction Panel, TBD |
| 12:50-1:00 | Closing & Invite to 2027 BioPharma Boston! |
| 1:30 | Boxed Lunch |
| 2:00-4:30 | Walk, Connect & Explore Boston Extend your BioPharma Boston experience with a relaxed, guided walking tour through historic streets, connecting with fellow ASAP attendees along the way. The tour concludes with a happy hour drink, a great way to unwind and enjoy the city before heading home. Minimum 6 participants; maximum 20. An additional fee applies. Sign up under Networking Add-Ons in the conference registration. |
Registration
Conference Rate - $2,699 / $2,299 early rate ends 9/25
Member Rate - $2,159 / $1,839 early rate ends 9/25
“ASAP’s BioPharma Conference is unequivocally the most valuable event I attend each year. The rich content and community elevate my career and alliance capabilities."
Logistics
Venue & Room Block
Renaissance Boston Seaport District
606 Congress Street, Boston, MA 02210
Reserve Now
ASAP has secured discounted room rate of $269+ per/night (until October 19, 2026 or when the block is full).
Justification Letter
To help secure approval for your participation, customize this letter.
"The ASAP BioPharma Conference is a transformative experience that brings together the brightest minds in the industry. The insights and connects are invaluable."
Sponsors
We’re grateful to our sponsors whose support makes this event possible and strengthens the entire ASAP community. Their partnership enables us to deliver meaningful programs and experiences throughout the year. Interested in becoming an ASAP sponsor? Visit our sponsorship page to learn more and connect with us.
Platinum Level
Gold Level
Silver Level
Bronze Level
